Novo Nordisk A/S (NVO) NYSE
36.53
-0.55(-1.48%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
36.53
-0.55(-1.48%)
Currency In USD
| Market Cap | 1.44T |
| Enterprise Value | 1.54T |
| P/E Ratio | 10.3 |
| PEG Ratio | -8.29 |
| Price/Sales Ratio | 3.41 |
| Price/Book Ratio | 5.44 |
| Enterprise/Revenue | 3.75 |
| Enterprise/EBITDA | 7.22 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.33 |
| Operating Margin | 0.41 |
| Return On Assets | 0.19 |
| Return On Equity | 0.61 |
| Revenue | 297.2B |
| Revenue/Share | 69.55 |
| Gross Profit | 238.77B |
| EBITDA | 143.94B |
| Net Income | 98.5B |
| Diluted EPS | 23.03 |
| Total Cash | 26.96B |
| Total Cash/Share | 6.07 |
| Total Debt | 130.96B |
| Total Debt/Equity | 0.67 |
| Current Ratio | 0.8 |
| Book Value Per Share | 43.67 |
| 52-Week Change | -53.64 |
| 52-Week High | 81.44 |
| 52-Week Low | 35.85 |
| Moving Average 50 Days | 49.09 |
| Moving Average 200 Days | 55.25 |
| Average Volume | 24.83M |
| Shares Outstanding | 4.44B |
| % Held by Institutions | 7.07 |
| Trailing Annual Dividend Rate | 11.65 |
| Trailing Annual Dividend Yield | 4.91 |
| Payout Ratio | 0.51 |
| Last Split Factor | 2:1 |
| Last Split Date | September 20, 2023 |